CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
LifeWrap Compression Garmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03484273
NCT03484273N/ACompleted

Body Compression in Postural Tachycardia Syndrome (POTS): Effects on Orthostatic Tolerance

University of Calgary·interventional·Posted Mar 30, 2018·Updated Oct 22, 2021

In Brief

A clinical study evaluating LifeWrap Compression Garment for Postural Tachycardia Syndrome. Completed, enrolled 32 participants across 1 site.

Detailed Summary

When an individual with Postural Tachycardia Syndrome (POTS) stands up, their heart rate increases significantly (\>30BPM) and they may experience symptoms such as lightheadedness, dizziness, shortness of breath, nausea and mental confusion. One commonly prescribed treatment for POTS is compression garments. Compression garments squeeze veins to help return blood back to the heart, which may decrease heart rate and symptoms on standing. However, there is little research about the effectiveness of compression in adults with POTS. In this study, the investigators will use the Lifewrap garment, which compresses the abdomen, pelvis and lower extremities, to evaluate the effectiveness of compression in POTS. The investigators will use a head up tilt (HUT) which will simulate standing. The study participant will participate in 4x 10 minute HUTs wearing 4 different compression configurations: 1. full abdomen and lower extremity compression 2. abdominal only compression 3. leg only compression 4. No compression The investigators hypothesize that with full compression, the participant's heart rate increase from lying down to upright will be lower than when they are not wearing any compression. The investigators will also ask the participant about their symptoms when they are upright. The results of this study could demonstrate the potential benefits of compression and what configuration is most effective. These findings could rapidly translate to the clinical setting, providing improved care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 30, 2018
Enrollment StartJul 12, 2018
Primary CompletionApr 1, 2020
Study CompletionJan 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.3 years ago

Interventions

LifeWrap Compression Garmentdevice

Non-Pneumatic Anti-Shock (NASG) compression garment comprised of neoprene with velcro closures.